It is now well-recognized that changes in metabolic events underlie the pathogenesis of many diseases including diabetes, obesity, inflammatory bowel disease (IBD) as well as cardiovascular diseases such as atherosclerosis. The research mission of this program is to develop a better understanding of the molecular and metabolic changes that lead to diseases such as diabetes, obesity, IBD and atherosclerosis.